Treace Medical Concepts Inc (TMCI)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $345.50M
Last updated: Nov 17, 2026 at 11:05 AM ET
Treace Medical Concepts Inc (TMCI) Stock Forecast
Analysts expect Treace Medical Concepts (TMCI) to earn -$0.80 per share in the fiscal year ending Dec 31, 2026, on revenue of $207.87M. Of 5 analysts, 1 rates the stock Buy or Strong Buy, 3 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 5 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 3.20, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 20% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 1 | 20.0% |
| Hold | 3 | 60.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 1 | 20.0% |
- Consensus
- Hold
- Total analysts
- 5
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates rise 6.1%.
- Fiscal year ending Dec 31, 2026
- -$0.80
- EPS consensus, revenue $207.87M
- Fiscal year ending Dec 31, 2027
- -$0.85
- EPS consensus, revenue $220.59M
- Next report
- Feb 25, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.80 | -$0.81 to -$0.80 | 4 | $207.87M | $207.64M to $208.02M | 5 |
| Dec 31, 2027 | -$0.85 | -$0.85 to -$0.85 | 1 | $220.59M | $218.40M to $223.70M | 5 |
Quarterly Estimates
The EPS consensus falls from -$0.08 for the quarter ending Dec 31, 2026 to -$0.26 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.08 | -$0.11 to -$0.05 | 7 | $68.61M | $65.56M to $71.40M | 7 |
| Mar 31, 2027 | -$0.26 | -$0.27 to -$0.26 | 3 | $50.80M | $50.40M to $51.00M | 3 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 7 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 5 | 0 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
| Quarter ending Mar 31, 2027 | 2 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$0.85.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.80 | -$0.85 | -$0.85 | -$0.85 | -$0.85 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.85 | -$0.90 | -$0.90 | -$0.90 | -$0.90 | N/A |
| Quarter ending Mar 31, 2027 | -$0.26 | -$0.25 | -$0.25 | -$0.25 | -$0.25 | N/A |
Frequently Asked Questions About TMCI
What is the TMCI stock forecast?
Consensus analyst estimates put Treace Medical Concepts's EPS at -$0.80 for the fiscal year ending Dec 31, 2026, on revenue of $207.87M. The consensus rating from 5 analysts is Hold.
How do analysts rate TMCI stock?
Of 5 analysts covering Treace Medical Concepts, 0 rate it Strong Buy, 1 Buy, 3 Hold, 0 Sell and 1 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from TMCI next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.80, with estimates from -$0.81 to -$0.80 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.85, with estimates from -$0.85 to -$0.85 from 1 analyst.
What revenue do analysts expect from Treace Medical Concepts next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $207.87M, with estimates from $207.64M to $208.02M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $220.59M, with estimates from $218.40M to $223.70M.
How many analysts cover TMCI?
5 analysts rate Treace Medical Concepts stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
TMCI pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts